A4001078 Maraviroc v Standard Therapy in Treatment Naïve HIV Patients

• Research type

  Research Study

• Full title

  Pilot Study of Novel Combination of Maraviroc + Atazanavir/Ritonavir Vs. Atazanavir/Ritonavir + Emtricitabine/Tenofovir For The Treatment Of Treatment Naïve HIV-Infected Patients With R5 HIV-1 Study Number: A4001078

• IRAS ID

  15686

• Contact name

  Alan Winston

• Contact email

  awinston@imperial.ac.uk

• Sponsor organisation

  Pfizer Inc, 235 East 42nd Street, New York, NY 10017

• Eudract number

  2008-007038-24

• ISRCTN Number

  NA

• Research summary

  Research Summary not published at request of researcher

• REC name

  Wales REC 3

• REC reference

  09/MRE09/13

• Date of REC Opinion

  19 May 2009

• REC opinion

  Further Information Favourable Opinion